Sponsor
Ashutosh Kumar Tewari
Clinical research sponsor
Clinical trials
3 shownIntratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active SurveillanceNCT06343077 · lead sponsor · 2024-01-16
RECRUITINGThe Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting.NCT05010200 · lead sponsor · 2022-01-05
ACTIVE_NOT_RECRUITINGNeoadjuvant Hiltonol® (PolyICLC) for Prostate CancerNCT03262103 · lead sponsor · 2017-06-16
COMPLETEDSponsor roles
lead sponsor3
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.